Skip to content




Blog, YouTube & Content Monetization

Not sure where to post? Just need to vent, share a thought, or throw a question into the void? You’re in the right place.

  1. Two romantasy authors have publicly defended their use of artificial intelligence after being caught with AI-generated prompts left in their published works. While their readers are far from impressed, the writers insist that it does not take away from their craft. Excerpts from novels published by K.C. Crowne and Lena McDonald have been spreading across Reddit, Goodreads, and Bluesky, after readers discovered revision notes that read like ChatGPT and cues that reference the style of other authors embedded in the copy. “I’ve rewritten the passage to align more with J. Bree’s style, which features more tension, gritty undertones, and raw emotional subtext beneath …

  2. The news landed quietly, tucked into a letter from MIT Sloan’s dean to colleagues: After 67 years, MIT Sloan Management Review is shutting down. Future insights, the letter explained, will live on via “digital newsletters, short-form video, social-first content, and podcasts.” This is a strategic inflection point for management thinking. It will have a major impact on the entire ecosystem through which serious management ideas travel from researchers to the people who run organizations. That ecosystem was already fragile. Winner-take-all dynamics MIT Sloan Management Review and similar journals were classic two-sided market propositions. They offered management…

  3. Think. Create. Change. These three verbs are the driving force behind the World Changing Ideas Summit, a first-of-its-kind event created in partnership with Fast Company and Johns Hopkins University (JHU). This November 19 at the Johns Hopkins University Bloomberg Center in Washington, D.C., the World Changing Ideas Summit will convene academics and senior business leaders for a day of immersive, thought-provoking experiences designed to advance America’s innovation ecosystem. From dynamic panels to interactive innovation showcases to hands-on breakout sessions, the World Changing Ideas Summit aims to go beyond dialogue and inspire action. “The World Changing…

  4. Despite a strong start to the year, traffic at U.S. quick service restaurants (QSR), which has been steadily declining month by month, was down 1.7% year-over-year compared to last April, signaling growing consumer caution or shifts in dining behaviors, according to Revenue Management Solutions (RMS), a company that analyzes data and provides insights about the restaurant industry. At the same time, RMS found on average, fast food prices increased in April by +2.0% year-over-year, steady with inflation trends. In case you’re not familiar with restaurant industry lingo, a quick service restaurant (QSR) describes establishments that prioritize speed and convenience,…

  5. The H&M group is entering the fall season with style. On Wednesday, September 24, the retailer released its third-quarter earnings and reported an operating profit of 4.9 billion Swedish krona ($521 million). The H&M group owns brands including H&M, COS, Monki, and Arket. Its operating profit marked a 40% increase year-over-year (YOY) and beat analysts’ predicted 3.7 billion Swedish krona ($393 million), according to consensus estimates cited by CNBC. The figures also marked consecutive quarterly successes for the H&M group, which also beat estimated operating profits in quarter-two. However, the H&M group now predicts that 2025’s quarter-four…

  6. A little less than eight months ago, Crusoe and Redwood Materials launched a new kind of project: a modular data center powered by solar panels and repurposed EV batteries. Now they have data showing it works—and they’re scaling up. Over the months that the solar microgrid has been in use, it’s run 99.2% of the time, outperforming the companies’ targets. And unlike other data centers that rely on fossil fuels, this one uses only clean power. It’s very different from the standard way to build a data center. “The normal approach would be to get in line with a utility, wait for any number of years, and hopefully one day get an approval and join the grid,” says Cully …

  7. We’re in the midst of a child care crisis in America, but when fathers want to take on more childcare to equal their partners’ efforts, they are being stymied by their employers. Max, who requested to go by a pseudonym, spent 15 years as a contractor: no benefits, little job security, and frequent change. When recruited for a full-time role, he was upfront about his wife’s pregnancy and his need to take parental leave when their first-born child was due. “I said, ‘I’m going to be flexible—I don’t have to take off right away and I can do it in stints.’ I was offering these different plans because it was important to me for the company to be successful,” Max says. “…

  8. In the past week, law enforcement agencies including the Federal Bureau of Investigation (FBI) and the Cybersecurity and Infrastructure Security Agency (CISA) have issued a warning about the ongoing threat of Medusa ransomware. Here’s what you need to know about the threat and how you can protect yourself. What is Medusa ransomware? Ransomware is a type of software that is designed to compromise your information, allowing hackers to steal it. Once these bad actors have your data, they then contact you (or the software contacts you on their behalf), and they inform you that unless you pay a ransom, your data will either be deleted, sold to the highest bidder, or rel…

  9. The Federal Communications Commission on Monday said it would ban new foreign-made drones, a move that will keep new Chinese-made drones such as those from DJI and Autel out of the U.S. market. The announcement came a year after Congress passed a defense bill that raised national security concerns about Chinese-made drones, which have become a dominant player in the U.S., widely used in farming, mapping, law enforcement,ss and filmmaking. The bill called for stopping the two Chinese companies from selling new drones in the U.S. if a review found they posed a risk to American national security. The deadline for the review was Dec. 23. The FCC said Monday the re…

  10. Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off. The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo Nordisk’s semaglutide. Previously, the highest approved dose of the drug, taken as a weekly shot, was 2.4 milligrams. The new dose received accelerated review through the FDA’s ultra-fast drug review program. The approval was granted 54 days after the request for review was approved, the agency said in a statement. The new dosage will be available in April at pharmacies in the U.S., with a price to be announced t…

  11. Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications like ibuprofen and acetaminophen. But the medication’s modest effectiveness and lengthy development process underscore the challenges of finding new ways to manage pain. Studies in more tha…

  12. The U.S. Food and Drug Administration approved Novo Nordisk’s weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly. The pill is 25 milligrams of semaglutide, the same active ingredient in injectable Wegovy and Ozempic, and will be sold under the brand name Wegovy. Novo already sells an oral semaglutide for type 2 diabetes, Rybelsus. The approval could help spur a turnaround for Novo after a rocky year of sliding shares, profit warnings and slowing sales of its injectable Wegovy amid intense competition from Lilly and pressure from c…

  13. The U.S. Food and Drug Administration blocked imports of spices this week from an Indonesian company amid widespread worries of radioactive contamination. The agency said it found cesium 137 in spices—specifically cloves—from Indonesian company PT Natural Java Spice that were shipped to California. The discovery marks the second food product imported from Indonesia found to have radioactive contamination, as recalls of potentially tainted imported shrimp expanded. “Products from PT. Bahari Makmur Sejati and from PT Natural Java Spice will not be permitted to enter the U.S. market until these firms provide the FDA with information to adequately demonstrate that th…

  14. On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk factors include medical conditions such as asthma, cancer, chronic kidney disease, heart disease and diabetes. However, healthy younger adults and children who fall outside of these groups may not be eligible to receive the COVID-19 shot this fall. Vaccine manufacturers will have to conduct clinical trials to demonstrate that the vaccine benefits low-risk g…

  15. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is honing in on infant formula in his food safety review. RFK Jr. says the U.S. Food and Drug Administration (FDA) will further test formula brands for heavy metals after some concerning results from Consumer Reports (CR) were released earlier this week. “The FDA will use all resources and authorities at its disposal to make sure infant formula products are safe and wholesome for the families and children who rely on them,” Kennedy said in a statement. HHS is calling the plan “Operation Stork Speed.” On Tuesday, CR revealed the results of testing on 41 types of powdered formula, from major labels such…

  16. The U.S. Food and Drug Administration is warning people to stop using certain types of glucose monitor sensors after the company that makes them, Abbott Diabetes Care, said the devices were linked to seven deaths and more than 700 injuries. Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors may provide incorrect low glucose readings, FDA officials said this week. Such readings over an extended period may lead people with diabetes to make bad treatment decisions, such as consuming too many carbohydrates or skipping or delaying doses of insulin. “These decisions may pose serious health risks, including potential injury or death,” the FDA said in the alert. The …





Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.

Account

Navigation

Search

Search

Configure browser push notifications

Chrome (Android)
  1. Tap the lock icon next to the address bar.
  2. Tap Permissions → Notifications.
  3. Adjust your preference.
Chrome (Desktop)
  1. Click the padlock icon in the address bar.
  2. Select Site settings.
  3. Find Notifications and adjust your preference.